跳至主要内容
临床试验/IRCT20190508043529N1
IRCT20190508043529N1已完成2 期

Continuous-light versus pulsed-light accelerated corneal crosslinking with ultraviolet-A and riboflavin in keratoconus patients

Shiraz University of Medical Sciences0 个研究点目标入组 124 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 30 years(—)
性别
All

入选标准

  • Progressive keratoconus (Progression of the disease was considered as confirmed if the loss of corrected distance visual acuity (CDVA) was more than one line in 1 year, or when the topographic keratometry increased by >1.0 D in 6 months or >2.0 D in 12 months)
  • The thinnest central corneal thickness (CCT) >400 µm

排除标准

  • Patients who wear contact lenses for one month prior to the initial evaluation and treatment
  • Patients with immune system disorders
  • Patients with corneal scar
  • Patients with history of herpes simplex keratitis
  • Patients who were pregnant or breastfeeding

研究者

相似试验